The American Association for Cancer Research (AACR) recently announced its newly elected class of Fellows of the AACR Academy. Fellows of the AACR Academy serve as a global brain trust of top contributors to cancer science and medicine who help advance the mission of the AACR to prevent and cure all cancers through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
Here are the members of the 2023 class of Fellows of the AACR Academy:
- Carolyn R. Bertozzi, PhD, of Stanford University and Howard Hughes Medical Institute, Stanford, California
- Stephen J. Chanock, MD, of the National Cancer Institute, Bethesda, Maryland
- George Coukos, MD, PhD, of Lausanne University Hospital and the Ludwig Institute for Cancer Research, Lausanne, Switzerland
- Hugues de Thé, MD, of Collège de France, Paris
- Julian Downward, PhD, of The Francis Crick Institute, London
- Laura J. Esserman, MD, MBA, of the University of California, San Francisco (UCSF), UCSF Breast Care Center, and UCSF Helen Diller Family Comprehensive Cancer Center
- Keith T. Flaherty, MD, of Harvard Medical School, Dana-Farber/Harvard Cancer Center, and Massachusetts General Hospital, Boston
- Andy Futreal, PhD, of The University of Texas MD Anderson Cancer Center, Houston
- Judy Lieberman, MD, PhD, of Harvard Medical School and Boston Children’s Hospital
- Patricia M. LoRusso, DO, PhD (hc), of Yale Cancer Center and Smilow Cancer Hospital, New Haven, Connecticut
- Luis F. Parada, PhD, of Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSK), and Weill Cornell Graduate School of Medical Sciences, New York
- Dana Pe’er, PhD, of Sloan Kettering Institute, Alan and Sandra Gerry Metastasis & Tumor Ecosystems Center, MSK, Howard Hughes Medical Institute, and Weill Cornell Medicine Graduate School of Medical Sciences, New York
- Charles M. Perou, PhD, of University of North Carolina Lineberger Breast Cancer Research Program and Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
- Helen Piwnica-Worms, PhD, of The University of Texas MD Anderson Cancer Center, Houston
- Thomas M. Roberts, PhD, of Harvard Medical School and Dana-Farber Cancer Institute, Boston
- Erkki Ruoslahti, MD, PhD, of Sanford Burnham Prebys, La Jolla, California
- Michel Sadelain, MD, PhD, of the Center for Cell Engineering, MSK, and Weill Cornell Medicine Graduate School of Medical Sciences, New York
- Kevan M. Shokat, PhD, of UCSF; Howard Hughes Medical Institute, Chevy Chase, Maryland; and the University of California, Berkeley
- Andreas Strasser, PhD, of the Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
- Jean Y. J. Wang, PhD, of the University of California San Diego School of Medicine, La Jolla
- Robert A. Winn, MD, of Virginia Commonwealth University Massey Cancer Center and Virginia Commonwealth University School of Medicine, Richmond
- Jedd Wolchok, MD, PhD, of the Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York
- Catherine J. Wu, MD, of Dana-Farber Cancer Institute and Harvard Medical School, Broad Institute of Massachusetts Institute of Technology, and Harvard University, Boston.
